Ident. | Authors (with country if any) | Title |
---|
000000 (2020) |
Cheng Liu [République populaire de Chine] ; Xiaojun Guo [République populaire de Chine] ; Sunpeng Bai [République populaire de Chine] ; Guangjun Zeng [République populaire de Chine] ; Hao Wang [République populaire de Chine] | lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast-like synoviocytes by downregulating IL-17 |
000006 (2020) |
Anna Jakubczyc ; Claus Neurohr | [Interstitial lung disease in rheumatic diseases - new therapeutic approaches]. |
000014 (2020) |
Puja Mehta ; Jessica J. Manson | What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis? |
000024 (2020) |
Joel Hirsh ; Patrick Wood ; Angela Keniston ; Dennis Boyle ; Itziar Quinzanos ; Liron Caplan ; Lisa Davis | Universal Health Literacy Precautions Are Associated With a Significant Increase in Medication Adherence in Vulnerable Rheumatology Patients |
000028 (2020) |
Evan A. Choate [États-Unis] ; Gurjit S. Kaeley ; Jenny Brook [États-Unis] ; Roy D. Altman [États-Unis] ; John D. Fitzgerald [États-Unis] ; Astrid R. Floegel-Shetty [États-Unis] ; David A. Elashoff [États-Unis] ; Veena K. Ranganath [États-Unis] | Ultrasound detects synovitis in replaced and other surgically operated joints in rheumatoid arthritis patients |
000029 (2020) |
Sara Benchérifa ; Bouchra Amine ; Imane El Binoune ; Samira Rostom ; Rachid Bahiri | Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy |
000030 (2020) |
Gulzhan Trimova ; Kaoru Yamagata ; Shigeru Iwata ; Shintaro Hirata [Japon] ; Tong Zhang ; Fumi Uemura ; Minoru Satoh [Japon] ; Norma Biln ; Shingo Nakayamada ; Walter P. Maksymowych ; Yoshiya Tanaka | Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages |
000037 (2020) |
Huiqiong Zeng ; Baiwei Luo ; Yue Zhang ; Zhongyu Xie ; Zhizhong Ye | Treatment of reactive arthritis with biological agents: a review |
000044 (2020) |
Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon] | Translating IL-6 biology into effective treatments |
000047 (2020) |
María Martín-L Pez [Espagne] ; Eliseo Albert [Espagne] ; Mario Fernández-Ruiz [Espagne] ; Isidoro González-Álvaro [Espagne] ; Esther Rodríguez [Espagne] ; José M. Aguado [Espagne] ; David Navarro [Espagne] ; José L. Pablos [Espagne] | Torque teno virus viremia in patients with chronic arthritis: Influence of biologic therapies. |
000048 (2020) |
Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie] | Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. |
000050 (2020) |
Daichi Fukaya [Japon] ; Tsutomu Inoue [Japon] ; Yuta Kogure [Japon] ; Hiroshi Kajiyama [Japon] ; Keisuke Ishizawa [Japon] ; Takeru Seto [Japon] ; Hajime Hasegawa [Japon] ; Toshihide Mimura [Japon] ; Hirokazu Okada [Japon] | Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases. |
000051 (2020) |
Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud] | Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review. |
000052 (2020) |
Yasuhiko Hirabayashi [Japon] | Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis. |
000054 (2020) |
Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine] | Tocilizumab treatment in Felty's syndrome. |
000058 (2020) |
Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon] | Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
000062 (2020) |
Athimalaipet V. Ramanan [Royaume-Uni] ; Andrew D. Dick [Royaume-Uni] ; Catherine Guly [Royaume-Uni] ; Andrew Mckay [Royaume-Uni] ; Ashley P. Jones [Royaume-Uni] ; Ben Hardwick [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Matthew Smyth [Royaume-Uni] ; Thomas Jaki [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] | Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial |
000065 (2020) |
Ian Pirker [Suisse] ; Andrea Rubbert-Roth [Suisse] ; Johannes Von Kempis [Suisse] ; Martin Fehr [Suisse] ; Thomas Neumann [Suisse] | Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy. |
000082 (2020) |
Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud] | The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus |
000089 (2020) |
Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis] | The paradox of cancer genes in non-malignant conditions: implications for precision medicine |
000091 (2020) |
Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France] | The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis. |
000092 (2020) |
Camilla Br Dsgaard Nielsen [Danemark] ; Christian Nielsen [Danemark] ; Mads Nybo [Danemark] ; S Ren Andreas Just [Danemark] ; Pernille Just Vinholt [Danemark] | The in vitro effect of antirheumatic drugs on platelet function. |
000093 (2020) |
Yuan-Yang Cheng [Taïwan] ; Shin-Tsu Chang [Taïwan] ; Chung-Lan Kao [Taïwan] ; Yi-Huei Chen [Taïwan] ; Ching-Heng Lin [Taïwan] | The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis |
000094 (2020) |
Ashish Sharma [Inde] ; Ashok Kumar [Inde] ; Alka Jha [Inde] ; Anunay Agarwal [Inde] ; Anoop Misra [Inde] | The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis – a cross-sectional study |
000104 (2020) |
Wei Zhang [République populaire de Chine] ; Qiying Zhang [République populaire de Chine] ; Zihua Xuan [République populaire de Chine] ; Juan Liang [République populaire de Chine] ; Dongping Yang [République populaire de Chine] ; Meihuizi Ding [République populaire de Chine] ; Housheng Zhu [République populaire de Chine] ; Bo Su [République populaire de Chine] ; Xing Dai [République populaire de Chine] ; Xiaoyi Jia [République populaire de Chine] | The Protective Effect of Different Polar Solvent Extracts of Er Miao San on Rats with Adjuvant Arthritis |
000107 (2020) |
Kyung Eun Kim ; Suwon Jeon ; Jisun Song ; Tae Sung Kim ; Min Kyung Jung ; Myun Soo Kim ; Sunyoung Park ; Seung Beom Park ; Jeong Min Park ; Hyun Jeong Park [Corée du Sud] ; Daeho Cho | The Novel Synthetic Peptide AESIS-1 Exerts a Preventive Effect on Collagen-Induced Arthritis Mouse Model via STAT3 Suppression |
000109 (2020) |
Eric Toussirot [France] | The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition |
000118 (2020) |
Gregory S. Calip [États-Unis] ; Pritesh R. Patel [États-Unis] ; Karen Sweiss [États-Unis] ; Zhaoju Wu [États-Unis] ; Jifang Zhou [États-Unis] ; Alemseged A. Asfaw [États-Unis] ; Sruthi Adimadhyam [États-Unis] ; Todd A. Lee [États-Unis] ; Brian C-H Chiu [États-Unis] | Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma. |
000126 (2020) |
E C Schwaneck [Allemagne] ; R. Renner [Allemagne] ; L. Junker [Allemagne] ; H-P Tony [Allemagne] ; S. Kleinert [Allemagne] ; M. Gernert [Allemagne] ; M. Schmalzing [Allemagne] ; O. Gadeholt [Allemagne] | T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy. |
000134 (2020) |
Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde] | Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis. |
000139 (2020) |
Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France] | Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study |
000143 (2020) |
Eduardo Mysler [Argentine] ; Mario H. Cardiel [Mexique] ; Ricardo M. Xavier [Brésil] ; Alejandra L Pez ; Allan Ramos-Esquivel [Costa Rica] | Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study. |
000151 (2020) |
Joanna Wai Yee Leong [Singapour] ; Peter P. Cheung [Singapour] ; Sajeewani Dissanayake [Singapour] ; Warren Weng Seng Fong [Singapour] ; Keng Hong Leong [Singapour] ; Ying Ying Leung [Singapour] ; Anita Yee Nah Lim [Singapour] ; Nai Lee Lui [Singapour] ; Mona Manghani [Singapour] ; Amelia Santosa [Singapour] ; Melonie Kannamma Sriranganathan [Singapour] ; Ernest Suresh [Singapour] ; Teck Choon Tan [Singapour] ; Gim Gee Teng [Singapour] ; Manjari Lahiri [Singapour] | Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis. |
000155 (2020) |
Meng Xu ; Congcong Liu ; Lishuang Guo ; Sirui Yang | Severe sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report |
000156 (2020) |
Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon] | Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients. |
000159 (2020) |
Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes |
000162 (2020) |
Alexandre Sepriano [Oman] ; Andreas Kerschbaumer [Autriche] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas] | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. |
000163 (2020) |
Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France] | Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry. |
000164 (2020) |
Giulia Cassone ; Andreina Manfredi ; Fabiola Atzeni ; Vincenzo Venerito ; Caterina Vacchi ; Valentina Picerno ; Federica Furini ; Gian Luca Erre ; Paola Tomietto ; Anna Laura Fedele [Italie] ; Giovanni Della Casa [Italie] ; Valeria Nucera ; Chiara Giannitti [Italie] ; Carlo Salvarani ; Marco Sebastiani | Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study |
000166 (2020) |
Elyes Bouajina [Tunisie] ; Leith Zakraoui [Tunisie] ; Montassar Kchir [Tunisie] ; Samir Kochbati [Tunisie] ; Sofiene Baklouti [Tunisie] | Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice. |
000168 (2020) |
Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] | Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan |
000169 (2020) |
Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie] | Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. |
000181 (2020) |
Noha Mousaad Elemam [Émirats arabes unis] ; Suad Hannawi [Émirats arabes unis] ; Azzam A. Maghazachi [Émirats arabes unis] | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
000184 (2020) |
Maria C. Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; David Rosmarin [États-Unis] ; Joseph F. Merola [États-Unis] | Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa |
000187 (2020) |
Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine] | Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets |
000191 (2020) |
Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon] | Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study. |
000199 (2020) |
Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis] | Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status |
000203 (2020) |
Jae-A Park [Corée du Sud] ; Min-Young Lee [Corée du Sud] ; Jin Hyun Nam [États-Unis] ; Ju-Young Shin [Corée du Sud] ; Robert Wood [Royaume-Uni] ; Tim Holbrook [Royaume-Uni] ; Sun-Hong Kwon [Corée du Sud] | Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea. |
000204 (2020) |
Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Lenore Tominna [États-Unis] ; Ibrahim Abbass [États-Unis] | Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic. |
000205 (2020) |
Karin Luttropp [Suède] ; Johan Dalén [Suède] ; Axel Svedbom [Suède] ; Mary Dozier [États-Unis] ; Christopher M. Black [États-Unis] ; Amy Puenpatom [États-Unis] | Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review |
000220 (2020) |
Jamie E. Collins ; Fredrik D. Johansson ; Sara Gale ; Seoyoung Kim ; Swastina Shrestha ; David Sontag ; Jacklyn Stratton ; Huong Trinh ; Chang Xu ; Elena Losina ; Daniel H. Solomon | Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development |